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Abstract 
Objectives 
Describe the prevalence and determinants of HIV stigma in 21 communities in Zambia and 
South Africa. 
Design 
Analysis of baseline data from the HPTN071 (PopART) cluster-randomised trial. HIV stigma 
data came from a random sample of3859 people living with HIV. Community-level 
exposures reflecting HIV fears and judgementsand perceptions of HIV stigma came froma 
random sample of community members not living with HIV (n=5088), and from health 
workers(n=851). 
Methods 
We calculated the prevalence of internalised stigma, and stigma experienced in the 
community orin a healthcare settingin the past year. We conducted risk-factor analyses using 
logistic regression, adjusting for clustering. 
Results 
Internalised stigma (868/3859,prevalence 22.5%) was not associated with sociodemographic 
characteristics but wasless common among those with a longer period since diagnosis 
(p=0.043). Stigma experienced in the community (853/3859, 22.1%) wasmore common 
among women (p=0.016), older (p=0.011) and unmarried (p=0.009) individuals, those who 
haddisclosed to others (p<0.001), and those with more lifetime sexual partners (p<0.001). 
Stigma experienced in a healthcare setting (280/3859, 7.3%) was more common among 
women (p=0.019) and those reportingmore lifetime sexual partners (p=0.001) and higher 
wealth (p=0.003). Experienced stigmawas more common in clusters where community 
members perceived higher levels of stigma, but was not associated with the beliefs of 
community members or health workers.  
Conclusions 
HIV stigma remains unacceptably high in South Africa and Zambia and may act as barrier to 
HIV prevention and treatment. Further research is needed to understand its determinants. 
Funding 
HPTN 071 (PopART) is sponsored by the National Institute of Allergy and Infectious 
Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617 and 
UM1-AI068613, with funding from the US President’s Emergency Plan for AIDS Relief 
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(PEPFAR). Additional funding is provided by the International Initiative for Impact 
Evaluation (3ie) with support from the Bill & Melinda Gates Foundation, as well as by 
NIAID, the National Institute on Drug Abuse (NIDA) and the National Institute of Mental 
Health (NIMH), all part of NIH. The content is solely the responsibility of the authors and 
does not necessarily represent the official views of the NIAID, NIMH, NIDA, PEPFAR, 3ie 
or the Bill & Melinda Gates Foundation.  
James Hargreaves, Anne Stangl, and Shari Krishnaratne are members of the STRIVE 
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STRIVE consortium is funded by UKaid from the Department for International Development 
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department’s official policies. 
Keywords: HIV; AIDS; stigma; Epidemiology; Implementation science; Africa 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
 
 
Author contributions 
JH conceived the analysis and led the writing of the paper. SKundertook the analysis and 
assisted with the delivery of the study in the field. HM and PL contributed to the analysis.KS 
undertook literature review. HM, NM, andTM,led delivery of the study in the field. AScand 
RV oversaw data management and quality assurance. DD, HA and RJ designed and led the 
cluster-randomised trial and population cohort study within which the study is nested. EP-M 
oversaw the laboratory testing. GH and VB were responsible for the in-country management 
including data collection and withASt designed the questions on stigma included in this 
analysis and are co-investigators on the study protocol. All authors contributed to writing the 
paper and have agreed the final draft for submission. 
 
We thank Triantafyllos Pliakas for his help on the statistical analysis. 
 
 
 
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
 
 
Introduction 
HIV stigmais presentwhen HIV infection is linked to negative stereotypes that mark a person 
living with HIV as different from rest of the population; a separation of “them” from “us”. 
This separation then leads to status loss, which can result in negative outcomes for people 
living with HIV (PLHIV)[1].Stigma experienced byPLHIV can include being gossiped about, 
insulted or physically assaultedin communities and healthcare settings[2]. Internalized 
stigmaoccurs whenPLHIV apply the same negative feelings to themselvesand can have 
mental health consequences[3-6]. HIV stigma infringes human rights and can inhibit access 
to HIV testing andcare[7, 8]. 
Fewstudies have compared data both from those whose beliefs and behaviours are thought to 
drive the stigmatization process and also from those who experience it. The community-level 
factors that give rise to stigma are under-studied[9, 10]. Stigma theories suggest that the 
beliefs and behaviours of community members and health workers are drivers of stigma[11, 
12],but there are few quantitative data to support this.  
We analysedbaseline data from alarge cohort study of HIVstigma nested within the 
HPTN071(PopART) trial[13, 14].The outcomes of interest wereexperienced and internalised 
stigma reported by PLHIV. We firstexploredindividual-levelrisk factors. We theninvestigated 
the hypothesisthat stigma reported by PLHIV was more common in communities with higher 
levels of fear and judgement towards PLHIV. Finally, we investigated whether stigma 
reported by PLHIV was more common in communities withmore perceived stigma reported 
by community members andhealth workers. 
Methods 
21urbancommunities (9 in South Africa, 12 in Zambia)were purposively selected to take part 
in the HPTN071 (PopART) cluster-randomised trial. The trial teststhe impact of a 
combination HIV prevention package, including universaldoor-to-door HIV testing and offer 
of ART regardless of CD4 count, on HIV incidence.Using a “parallel” approach[15, 16], we 
combined outcome and exposure data from three separate populations who were interviewed 
in two data collection activities (see AppendixS1 and below for further details). 
  
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
 
 
Stigma outcome measurement 
Outcome data came from individuals recruited to the HPTN071 (PopART)Population Cohort 
who both self-reported living with HIV and were laboratory-confirmed as HIV-positive. We 
refer to this group as PLHIV. HIV status was determined by testing blood samples drawn 
from consenting survey participants. Blood samples were analysed in-country using a single 
4th generation assay (Architect HIV Ag/Ab Combo Assay, Abbott Diagnostics, Delkenheim 
Germany). Further testing was performed at the HPTN Laboratory Center (Baltimore, MD, 
USA). Samples that had reactive results in-country were tested with a second 4th generation 
assay (GS HIV Combo Assay, Bio-Rad Laboratories, Redmond, Wa). Samples with 
discrepant/discordant test results were tested with additional assays to determine HIV 
status.The cohort was enrolled between November 2013 and March 2015. Ineach community, 
household listing generated a sample frame[17]. The target sample size was 2500 individuals 
per community, of whom 15% were expected to be living with HIV. Inrandomly sampled 
households, one adult resident aged 18 to 44 years was selected at random. Participants 
completed an interviewer-administered questionnaire with data capturedon an electronic 
device. Participants were asked if they had previously had an HIV-test, and if comfortable to 
do so, to share the result of their last test[13].Participants were also offered voluntary 
counselling and testing using rapid HIV test-kits. Individuals testing positivewere referred to 
a government health facility. 
PLHIV were asked about their experiences of stigma. Item wording was informed by 
previous harmonisation work on measures of HIV stigma[18]. PLHIV responded to three 
items on internalised stigma (see Table 1 for item and response wording). Responses were 
summarised into a binary variable describing whether participants agreed to feeling any of 
three manifestations of internalised stigma. Five items captured experienced stigma in a 
community setting, and three captured stigma experienced in healthcare settings. Pre-coded 
response categories identified the frequency of experiences during the last year. These items 
were collapsed to create two binary variables capturing experience of stigma, in the 
community or in a healthcare setting, during the last year. 3,859 PLHIVhad complete data on 
all eleven stigma items and on all sociodemographic variables(Figure S1a). 
Exposure measurement 
Individual-level exposure data came from the same interviews with PLHIV as the outcome 
data. Exposures considered included sex, age, education, marital status, HIV treatment (i.e. 
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ever started ART), HIV-status disclosure, sexual behaviour and household wealth 
(AppendixS1).  
We also measuredcommunity-level characteristics reflecting the level of HIV fear and 
judgement and the perceptions of stigma reported by community-members and 
healthworkers.The HIV fear and judgement items captured participants’ attitudes towards 
PLHIV. The perceptions of stigma questions reflected whether participants perceived that 
stigma was occurring rather than reflecting their attitudes. Data were collected from a random 
20% sample of the Population Cohort described above. We included data 
fromparticipantswho did nothave a confirmed HIV-positive blood testor self-report being 
HIV-positive (5088 individuals, range 161 to 441 per community). We refer to this group as 
CM.We askedCM about theirfears and judgement toward PLHIV (3 items), levels of 
perceived stigma in communities (5 items), and levels of perceived stigma in healthcare 
settings (2 items). Each question was asked on a4-point Likert scalescored as follows 
(strongly disagree 0, disagree 1, agree 2, strongly agree 3) (Figure S1b). Three scores were 
calculated for each individual as the mean of the item responses. Each score could 
theoretically range from 0 to 3, with 0 representing all items being responded to as “Strongly 
Disagree” and 3 representing all “Strongly Agree”[19]. Clustersummary variables were 
calculated as the mean of the individual responses, with higher scores representing 
communities with a greater presence of stigmatising attitudes or a higher level of perceived 
stigma. Thus, for any community, a score of “1” would mean that the average response to all 
items across all individuals was to “Disagree” with the statements.  
Data on the beliefs and perceptions of health workers came from the baseline survey for a 
separate cohort study conducted as part of the trial[15]. We recruited consenting health-
facility staffandcommunity health workersdelivering HIV-related services. We also collected 
data from new trial intervention staff (known as “CHIPS”[13]) but excluded these from this 
analysis since these individuals had only just begun to work in the communities at the time of 
data collection. Weincluded data only from health workers who did not self-report being 
HIV-positive. We refer to this group as HW. Again, three scores were developed reflecting 
HIV fear and judgement(4 items), perceptions of the stigmatising behaviours of their co-
workers (4 items) and perceptions of stigma in the community (5 items).Scoring at individual 
and community-level was as above.Some 851health workers contributed data to this analysis 
(range 13 to 77 per community) (Figure S1c) 
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Statistical analysis 
We summarised PLHIVcharacteristics in each country and describevariation in stigma 
prevalenceby cluster (range). There was one cluster with a low sample size (n=5 PLHIV) 
leading to outlier values. Where relevant we present the outlier value separately, and the 
cluster range excluding this value. We calculated Cronbach’s alpha to assess inter-item 
agreement. 
In risk factor analysis we assessed whether both individual-level and cluster-level 
characteristics were associated with each of the three PLHIV stigma outcomes (internalised, 
experienced in the community, experienced in a healthcare setting). We used logistic 
regression and report the odds ratios and 95% confidence intervals and Wald-test values for 
each risk factor for each of the three outcomes in turn. Regression analyses were carried out 
excluding categories where a response was “Don’t know” (Ever started ART) or missing 
(time since first positive HIV test, first time had sex, number of sexual partners, and condom 
use). We examinedthe impact of missing data on these four risk factors on the three stigma 
outcomes and found that PLHIV with missing data were less likely to report HIV stigma. We 
adjusted the standard errors using the vce (cluster) command in Stata v14 to reflect the study 
design, and adjusted all analyses for sex and age.In Appendix S2 we report on a sensitivity 
analysis restricted to 2342 PLHIV who, at the time of recruitment to the study, had not yet 
had a visit from the trial intervention team. We were concerned that this visit may influence 
stigma reporting. In summary, the prevalence of stigma was largely unchanged and while 
there were changes in point estimates and significance values for individual variables there 
were no systematic differences of interpretation. 
For individual-level risk factor analysis we included sociodemographic and sexual behaviour 
characteristics that have been associated with stigma in previous analyses[20, 21].For cluster-
level risk factor analysis we hypothesised that PLHIV-reported levels of internalised stigma 
and stigma experienced in the community would be correlated with the level of HIV fearand 
judgementreported by CM, and with perceived levels of community stigma reported by CM 
and HW. We hypothesised that stigma reported by PLHIV in healthcare settings would be 
correlated with thelevel of HIV fear and judgement reported by HW, with perceived levels of 
stigma in healthcare settings reported by CM,and with perceptions of stigma among co-
workers reported by HW. To aid interpretation, weproduced cluster-level scatter plotsof the 
associations between the prevalence of each type of stigma and the cluster-level exposures. 
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Each cluster was represented by a circle proportional in size to the number of PLHIV 
included in the analysis. We added fit lines from unadjusted,cluster-level linear regressions of 
the associations weighted by the size of the PLHIV population in each cluster. 
Ethics 
TheHPTN 071(PopART) trial (Division of AIDS [DAIDS] #11865 and Clinical Trials 
registration number NCT01900977) and the stigma ancillary study (DAIDS # HPTN 071a) 
received institutional review board (IRB) approval from the London School of Hygiene and 
Tropical Medicine LSHTM, the Health Research Ethics Committee, Stellenbosch University, 
and the Biomedical Research Ethics Committee at the University of Zambia. Written 
informed consent was sought and obtained from all participants for all aspects of the 
research.  
Results 
Sociodemographic and behavioural characteristics of PLHIV 
Outcome data were available from 3859PLHIV (ranging from 60to 411 PLHIV by study 
community, with one outlier community, which only had 5 PLHIV). Most participants were 
women (86.0%Zambia, 90.9% South Africa; Table 1a). Most had attended secondary school, 
with more doing so in South Africa than Zambia (80.6% vs 45.8%). More Zambian 
participants were married (61.7%) than in South Africa (30.8%). Approximately 70% of 
PLHIV reported that they had ever started antiretroviral therapy in both countries. Less than 
10% of individuals reported that they had not disclosed their HIV status to anyone. Among 
those who had, disclosure was most commonly to a family member or a marital or sexual 
partner.Some 37.6% of PLHIV in South Africa, and 41.9% in Zambia, had been diagnosed 1-
5 years previously. Characteristics of sexual behaviour most commonly reported were age at 
first sex 16-18 years, 2-5 lifetime sexual partners and condom use at last sex.  
Prevalence of stigma reported by PLHIV 
22.5% of PLHIV (868/3859) agreed or strongly agreed with one of the three items reflecting 
internalised stigma(cluster range 1.9%-35.4%, outlier cluster80.0%, Table 2).Agree responses 
were more common than strongly agree.Inter-item agreement was high (Cronbach’s alpha 
0.82). Internalised stigma was more common in Zambian than South African clusters (25.9% 
vs 18.2%,p<0.001).22.1%of PLHIV(853/3859)reported at least oneof the five itemsreflecting 
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stigma experienced in the community (cluster range6.4%-36.8%, outlier cluster 80.0%). 
Across items, 6.0-9.2% of individuals reported the experiences had not happened because 
their status was unknown. Most events were experienced once or a few times rather than 
often. Inter-item agreement was again high (alpha 0.92). Reportedexperiences of stigmain the 
community weremore common among Zambianthan South African clusters (24.7% vs 
18.8%, p <0.001).7.3% of PLHIV (280/3859) reportedat least oneof the three items reflecting 
healthcare setting experiences of stigma in healthcare settings(1.0% -21.8%, outlier cluster 
60.0%), and more commonly in South African than Zambian communities (8.7% vs 6.1%, 
p<0.001). Inter-item agreement was again high (alpha 0.90).Overall, the prevalence of 
reporting any type of stigma was 35.5% (1371/3859). 
Community-level characteristics 
The cluster-score reflecting fear and judgement towards PLHIV reported by CM was 0.9 in 
South Africa and 0.8 in Zambia (Table 1b), with substantial variation between clusters (range 
0.4-1.2).Note that a score of 0.9 represents that across all communities the average participant 
response was closer to “Disagree” (1) than to “Strongly Disagree” (0). On average, CM 
also“disagreed” with statements regarding the perception that stigma was present in 
communities (1.2 South Africa, 1.3 Zambia) and healthcare settings (1.1 South Africa, 0.9 
Zambia), again with large inter-cluster variation. Health workers on average disagreed with 
statements reflecting HIV fear and judgement (mean 0.8 in both South Africa and Zambia), 
and there was less variation across clusters (range 0.6-1.1). Health workers reflected a 
somewhat higher score with regard to statements about the perception of stigma in 
communities (mean 1.5South Africa, 1.4 Zambia), but disagreedon average with statements 
about their co-workers stigmatising PLHIV (0.8 South Africa, 1.0 Zambia), with moderate 
variation across clusters. For all scores, consistency among items was moderate to high 
(Cronbach’s alpha 0.66 – 0.84, Table 1b). 
Risk factor analysis 
Internalised stigmawas not significantly associated with sociodemographic or behavioural 
characteristics, except that it was reported less often by those who had been diagnosed for 
longer (aOR 0.75 95% CI 0.59-0.96, and aOR 0.73 95% CI 0.56-0.96, comparing 1-5 years 
and 5+ years since diagnosis with 0-12 months, respectively).There was some evidence of 
more internalised stigma reported by those of higher wealth (p=0.065).Internalised stigma 
was more commonly reported by those reporting stigma experienced in both community and 
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healthcare settings (aOR 4.32 95% CI 3.47-5.37 and 4.37 95% CI 2.71-7.06, respectively) 
(Table 3).Internalised stigma was not significantlyassociated with living in a community with 
a higher score forHIV fear and judgement held by CM (adjusted odds ratiofor a unit increase 
in the score, aORscore1.1195% CI 0.36-3.44). However, internalised stigma was significantly 
associated withthe average level of perceived stigma reported byCM(aORscore 3.3695% CI 
1.86-6.10). There was little evidence of an association betweeninternalised stigma and the 
HWsperceptions of the level ofstigma in the community(aORscore 0.1695% CI 0.01-2.34) 
(Table 4). These findings were mirrored in the cluster-level scatter plots (Figure 1). 
Stigma experienced in the community was more frequently reported bywomen than men 
(aOR 1.22 95% CI 1.04-1.43), older individuals(aOR 1.5895% CI 1.15-2.17comparing 35-44 
with <=24 year olds) and thosewho were currently unmarried (aOR0.7795% CI 0.63-0.94 
comparing married with unmarried). This form of stigma was more commonly reported by 
those who had disclosed their HIV status (aOR1.99 95%CI 1.51-2.63), and had been 
diagnosed longer ago (aOR2.04 95%CI 1.59-2.63 comparing 5+ years with 0-12 months 
since diagnosis), as well as those reporting more lifetime sexual partners (e.g., aOR3.91 
95%CI 1.80-8.49 comparing >20 partners with 1 partner in lifetime). Stigma was more 
commonly experienced in the community among individuals who had also experienced 
stigma in ahealthcare setting (aOR 26.28 95% CI 13.22-52.26)(Table 3).The proportion of 
PLHIV experiencing stigma in the community was not associated with living in a community 
with a higher score forfear and judgementin CM’s attitudes(aORscore0.8995% CI 0.31-2.58), 
but was associated with the level ofperceived stigma in the community reported by 
CM(aORscore 3.2795% CI 1.31-8.19). There was little evidence of an association between 
community-experienced stigma and HW’sperceptions of stigma in communities 
(aORscore0.3495%CI 0.07-1.71) (Table 4). 
Stigma experienced in a healthcare setting was more commonly reportedbywomen than men 
(aOR1.6495% CI 1.08-2.48), and among thosereporting more lifetime sexual partners (e.g., 
aOR2.2495%CI 0.91-5.49 comparing >20 partners with those with 1 partner) (Table 3). Odds 
ratios for the associations between community level characteristics and stigma experienced in 
a health setting had wide confidence intervals (Table 4).Despite this, there wasevidence of an 
association such thatCMperceptions that stigma was present in healthcare settings was 
associated with PLHIV reports of this(aORscore14.93 95% CI 3.95-56.43). 
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Discussion 
In this large studyin 21 urbancommunities across two countries, 35.5% of 
PLHIVreportedsome type of stigma. Most PLHIV participants were women, reflecting both 
higher response rates and a higher prevalence of HIV among women. Individuals reporting 
one form of stigma were more likely to report the other types.Experienced stigma in the 
community and internalised stigma were more common in Zambian communities, while 
experienced stigma in healthcare settings was more common in South African 
communities.There were few individual predictors of internalised stigma, but experienced 
stigma was associated with sociodemographic and behavioural characteristics. At cluster 
level, community members’ (but not health workers) perceptions of stigma varied 
substantially across communities and were associated with PLHIV experiences. However, 
surprisingly, CM’s reported attitudes of fear and judgement toward PLHIV were not 
associated with PLHIV’s reported experiences of stigma. 
We have undertaken the largest ever study on experiences of stigma from a random sample of 
PLHIV, adopting best-practice measures of core manifestations of HIV stigma[7, 22, 23]. 
While some PLHIV did not participate in the study or did not disclose their status, response 
rates were high[24, 25]. We have brought data from PLHIV together with independently 
collected data on the beliefs and perceptions of HIVstigma held by community members and 
health workers. These fears, judgements and perceptions are thought to act as drivers of 
stigma in communities[26]. This “parallel” approach to data collection has been discussed in 
the literature[11, 15, 16] but not operationalised.Aside from the strengths of our 
work,thereare alsolimitations.  Stigma is a sensitive subject and may have been under 
reported. Social desirability bias might have affected the validity of responses to beliefs and 
perception questions[22, 23]. Since the communities involved in the study were purposively 
selected it is unclear how generalizable our findings are to other settings in sub-Saharan 
Africa.Wide confidence intervals for some associationsreflectsfew events for some outcomes, 
limited inter-cluster variation for some exposure variablesand the small number of 
clusters[27].Finally, results for risk factors with missing data should be interpreted with 
caution noting that PLHIV with missing data were less likely to report HIV stigma. 
Reported experience of stigma among PLHIV in our study was lower than in studies 
employing the PLHIV Stigma index in South Africa[26] and the Gambia[28]. In 2009 51.8% 
of PLHIV reported having experienced verbal abuse due to their HIV status in Zambia 
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compared to 8.3% in our study [25]. In another study, 16.1% of PLHIV reported physical 
abuse due to their HIV status compared to 4.6% in our population [26]. Previous studies were 
conducted on smaller, convenience or snowball samples. Individuals recruited this way may 
not be representative of all PLHIV. Participants may be more likely to discuss stigma in the 
PLHIV Stigma Index studies since these are partly used to encourage reflection on life 
experiences living with HIV [29, 30]. Some forms of stigma may be decreasing over time and 
as ART access expands, and this would be consistent with our findings [31]. Stigma 
manifestations may also be shifting with more nuanced forms of stigma replacing overt acts 
of stigma and discrimination [32].   
Some findings were as hypothesised. Experienced stigma was more common among those 
reporting more risk behaviour. Those who had been diagnosed for longer and who had 
disclosed to others reported more experienced stigma, perhaps reflecting their greater 
visibility. They also reported less internalised stigma, perhaps reflecting having had a longer 
period to “accept” their status[34-36]. Other findings were unexpected. While community 
members’ perceptions of levels of stigma were correlated with the reported experiences of 
PLHIV, neither their beliefs, nor the beliefs or perceptions of health workers were. This may 
reflect misreporting of either stigma experiences, or of beliefs, due to social desirability 
bias[22, 23]. However, our study used electronic data collection devices and sought to 
encourage honest reporting. Stigma reported by PLHIV might also have occurred outside the 
study communities or healthcare settings from which belief data were collected. 
Nevertheless, our resultssuggest caution in situations where reported fears and judgements 
are interpreted as a proxy for the experiences of PLHIV. It also underscores the role of 
internalised stigma in contributing to stigma experiences.   
Stigma remains an important phenomenon in these study communities. Ourresults will inform 
ongoing work addressing the core hypotheses for our nested study: that the HPTN 071 
(PopART) intervention may reduce levels of stigma in study communities, that stigma may 
undermine the effectiveness of efforts to scale up testing and treatment, or that the forms of 
HIV stigma may change over the period of the trial[15].  
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Table 1a: Sociodemographic and behavioural characteristics of 3859 people living with HIV who 
responded to survey items measuring internalized and experienced stigma 
 
South Africa  Zambia 
Individual Characteristics  n/1704 (%)  n/2155 (%) 
Sex  Male  155 (9.1%)  301 (14.0%) 
Female  1549 (90.9%)  1854 (86.0%) 
Age  <=24  166 (9.7%)  257 (11.9%) 
25‐34  827 (48.5%)  950 (44.1%) 
35‐44  711 (41.7%)  948 (44.0%) 
Education  Did not complete secondary  292 (17.1%)  1052 (48.8%) 
Completed secondary  1374 (80.6%)  986 (45.8%) 
Further  38 (2.2%)  117 (5.4%) 
Marital Status  Not Married  1180 (69.2%)  825 (38.3%) 
Married  524 (30.8%)  1330 (61.7%) 
Ever started ART  Yes  1185 (69.5%)  1505 (69.8%) 
No  172 (10.1%)  168 (7.8%) 
Don’t know  347 (20.4%)  482 (22.4%) 
Disclosed to 1  No‐one  118 (6.9%)  182 (8.4%) 
Husband/wife/sexual partner  644 (37.8%)  1062 (49.3%) 
Family member  1313 (77.1%)  1530 (71.0%) 
Friend/neighbour/colleague  301 (17.7%)  221 (10.3%) 
Religious leader/worker  26 (1.5%)  64 (3.0%) 
Health care worker  83 (4.9%)  106 (4.9%) 
Other  11 (0.6%)  25 (1.2%) 
How old were you the first 
time you had sex 
11­15  230 (13.5%)  402 (18.7%) 
16­18  891 (52.3%)  963 (44.7%) 
19­24  406 (23.8%)  558 (25.9%) 
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25+  12 (0.7%) 38 (1.8%)
Skipped/missing 165 (9.7%) 194 (9.0%)
How long has it been since 
your first positive HIV test? 
0­11 months 255 (15.0%)  495 (23.0%)
1­5 years  641 (37.6%)  902 (41.9%)
More than 5 years 369 (21.7%)  385 (17.9%)
Skipped/missing 439 (25.8%)  373 (17.3%)
How many sexual partners 
have you had in your lifetime? 
1  224 (13.1%)  415 (19.3%)
2­5  874 (51.3%)  1282 (59.5%) 
6­10  242 (14.2%)  168 (7.8%) 
11­15  29 (1.7%)  23 (1.1%) 
16­20  17 (1.0%)  11 (0.5%) 
More than 20  12 (0.7%)  28 (1.3%) 
Skipped/missing  306 (18.0%)  228 (10.6%) 
The last time you had sex, did 
you use a condom 
No  274 (16.1%)  727 (33.7%) 
Yes  1039 (61.0%)  818 (38.0%) 
Skipped/missing  391 (22.9%)  610 (28.3%) 
Wealth Tertile  Lowest  772 (45.3%)  775 (36.0%) 
Middle  614 (36.0%)  969 (45.0%) 
Highest  318 (18.7%)  411 (19.1%) 
Visit from community HIV 
care providers (CHiPs) 
No  1237 (72.6%)  1105 (51.3%) 
Yes  369 (21.7%)  996 (46.2%) 
Missing  98 (5.8%)  54 (2.5%) 
1: Multiple responses could be given and totals don’t add up to 100. Responses were aggregated as a binary variable for 
subsequent analysis to reflect whether individuals reported that they had disclosed their HIV status to no-one or to anyone. 
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Table 1b: Cluster level characteristics describing the beliefs and perceptions of community members and 
health workers 
Scores  N / Population 
(Range) 
Mean score ‐ 
South Africa 
(Cluster Range)
Mean score ‐ 
Zambia 
(Cluster Range) 
Cronbach's 
Alpha (items)
  9 clusters 12 clusters   
Average level of fear and judgement 
reported by CM   5088 (127‐382) 0.9 (0.4‐1.2)  0.8 (0.4‐1.1)  0.74 (3) 
Average level of perceived HIV stigma 
in the community reported by CM  5088 (127‐382) 1.2 (0.6‐1.9)  1.3 (0.8‐1.6)  0.84 (5) 
Average level of perceived HIV stigma 
in healthcare settings reported by CM  5088 (127‐382) 1.1 (0.6‐1.8)  0.9 (0.6‐1.3)  0.76 (2) 
Average level of HIV fear and 
judgement reported by HW  851(13‐ 77)  0.8 (0.6‐1.1)  0.8 (0.6‐0.9)  0.67 (5) 
Average level of perceived HIV stigma 
in the community reported by HW  851(13‐ 77)  1.5 (1.3‐1.8)  1.4 (1.3‐1.6)  0.66 (5) 
Average level of perceived co‐workers 
stigmatising behaviour reported by 
HW 
851(13‐ 77)  0.8 (0.6‐1.1)  1.0 (0.8‐1.1)  0.76 (4) 
 
CM: Community members not living with HIV; HW:Health workers not living with HIV.  
All scores have a theoretical range from 0 (all answers of all individuals ‘Strongly Disagree’) to 3 (all answers of all 
individuals ‘Strongly Agree’. A mean score of 1 indicates a person that, on average, responds “Disagree” to items within a 
score; a mean score of 2 indicates a person that on average responds “Agree”. 
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Table 2: Responses from People Living with HIV to items on internalised and experienced stigma 
items (n=3859) 
Internalised stigma 
Strongly 
Disagree 
Disagree  Agree 
Strongly 
Agree 
I have lost respect or standing in the community because 
of my HIV status 
1296 
(33.6%) 
2093 
(54.2%)
316 
(8.2%) 
154 
(4.0%)    
I think less of myself because of my HIV status 
1224 
(31.7%) 
2138 
(55.4%)
340 
(8.8%) 
157 
(4.1%)    
I have felt ashamed because of my HIV status 
1295 
(33.6%) 
2046 
(53.0%)
364 
(9.4%) 
154 
(4.0%)    
“Current internalised stigma”: Responding Agree or 
Strongly Agree to any of the above 
868/3859 (22.5%); South Africa (18.2%) vs 
Zambia (25.9%), p<0.001; 
Cronbach's alpha (0.82); cluster range (1.9%‐
35.4%); outlier 80.0% 
Frequency of experienced stigma (any setting)  Never 
Not 
disclose
d 
Once 
A few 
times 
Often 
People have talked badly about me because of my HIV 
status 
2908 
(75.4%) 
356 
(9.2%) 
233 
(6.0%) 
272 
(7.0%) 
90 
(2.3%
) 
Someone else disclosed my HIV status without my 
permission 
3119 
(80.8%) 
258 
(6.7%) 
277 
(7.2%) 
163 
(4.2%) 
42 
(1.1%
) 
I have been verbally insulted, harassed and/or 
threatened because of my HIV status 
3304 
(85.6%) 
234 
(6.1%) 
131 
(3.4%) 
156 
(4.0%) 
34 
(0.9%
) 
I have been physically assaulted because of my HIV status
3455 
(89.5%) 
230 
(6.0%) 
66 
(1.7%)  86 (2.2%)
22 
(0.6%
) 
I have felt that people have not wanted to sit next to me, 
for example on public transport, at church or in a waiting 
room because of my HIV status 
3387 
(87.8%) 
330 
(8.6%) 
76 
(2.0%) 
49 (1.3%)
17 
(0.4%
) 
“Experienced any stigma in past year”: Responding 
Once, A few times or Often (“ever”) to any of the 
above 
853/3859 (22.1%); South Africa (18.8%) vs 
Zambia (24.7%), p<0.001; 
Cronbach's alpha (0.92); cluster range (6.4%‐
36.8%); outlier 80.0% 
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Frequency of experienced stigma (health setting)  Never 
Not 
disclose
d 
Once 
A few 
times 
Often 
I have been denied health services because of my HIV 
status 
3627 
(94.0%) 
114 
(3.0%) 
55 
(1.4%)  51 (1.3%)
12 
(0.3%
) 
Healthcare workers talked badly about me because of my 
HIV status 
3558 
(92.2%) 
121 
(3.1%) 
101 
(2.6%)  66 (1.7%)
13 
(0.3%
) 
A health worker disclosed my HIV status without my 
permission 
3593 
(93.1%) 
103 
(2.7%) 
90 
(2.3%)  64 (1.7%)
9 
(0.2%
) 
“Experienced healthcare setting stigma in last year”: 
Responding Once, A few times or Often (“ever”) to 
any of the above 
280/3859 (7.3%); South Africa (8.7%) vs Zambia 
(6.1%), p=0.002; 
 Cronbach's alpha (0.90); cluster range (1.0%‐
21.8%); outlier 60.0% 
 
“Any stigma last year”: Yes to current internalised 
stigma, experienced any or healthcare setting stigma 
in last year”  
1371/3859 (35.5%); cluster range (11.4%‐55.8%); 
outlier 100.0% 
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Table 3:The association between sociodemographic and behavioural characteristics and three types of 
stigma among 3859 PLHIV from 21 study communities in Zambia and South Africa. 
    Any internalised stigma  Stigma experienced in the 
community 
Stigma experiences in a 
healthcare setting 
Variable  Categories 
n/N (%) 
aOR (95% 
CI)a  Pw
b  n/N (%) 
aOR (95% 
CI)a  Pw
b  n/N (%) 
aOR (95% 
CI)a  Pw
b 
Sex  Male  108/456 
(23.7%) 
1.00 0.136 92/456 
(20.2%) 
1.00 0.016 23/456 
(5.0%) 
1.00  0.019
Female  760/3403 
(22.3%) 
0.90 (0.78‐
1.03) 
  761/3403 
(22.4%) 
1.22 (1.04‐
1.43) 
  257/3403 
(7.6%) 
1.64 (1.08‐
2.48) 
 
Age  <24  111/423 
(26.2%) 
1.00  0.154 74/423 
(17.5%) 
1.00  0.011 17/423 
(4.0%) 
1.00  0.086
25‐34  402/1777 
(22.6%) 
0.82 (0.64‐
1.05) 
  370/1777 
(20.8%) 
1.25 (0.93‐
1.68) 
  130/1777 
(7.3%) 
1.91 (0.96‐
3.82) 
 
35‐44  355/1659 
(21.4%) 
0.75 (0.56‐
1.01) 
409/1659 
(24.7%) 
1.58 (1.15‐
2.17) 
133/1659 
(8.0%) 
2.19 (1.07‐
4.48) 
Education  Did not complete 
secondary 
334/1344 
(24.9%) 
1.00 0.277 326/1344 
(24.3%) 
1.00 0.063 78/1344 
(5.8%) 
1.00  0.352
Completed 
secondary 
500/2360 
(21.2%) 
0.81 (0.62‐
1.05) 
483/2360 
(20.5%) 
0.82 (0.62‐
1.07) 
191/2360 
(8.1%) 
1.45 (0.87‐
2.42) 
Further  34/155 
(21.9%) 
0.84 (0.59‐
1.18) 
  44/155 
(28.4%) 
1.28 (0.91‐
1.80) 
  11/155 
(7.1%) 
1.32 (0.69‐
2.53) 
 
Marital status  Not married  456/2005 
(22.7%) 
1.00  0.881 483/2005 
(24.1%) 
1.00  0.009 160/2005 
(8.0%) 
1.00  0.349
Married  412/1854 
(22.2%) 
0.98 (0.80‐
1.21) 
  370/1854 
(20.0%) 
0.77 (0.63‐
0.94) 
  120/1854 
(6.5%) 
0.77 (0.45‐
1.32) 
 
Ever started 
ART 
No  68/340 
(20.0%) 
1.00 0.631 70/340 
(20.6%) 
1.00 0.416 27/340 
(7.9%) 
1.00  0.792
Yes  590/2690 
(21.9%) 
1.14 (0.67‐
1.94) 
645/2690 
(24.0%) 
1.19 (0.78‐
1.81) 
197/2690 
(7.3%) 
0.89 (0.39‐
2.05) 
Don't know  210/829 
(25.3%) 
‐    138/829 
(16.6%) 
    56/829 
(6.8%) 
‐   
Disclosed to 
(ever disclosed 
HIV status) 
No  72/300 
(24.0%) 
1.00  0.578 38/300 
(12.7%) 
1.00  <0.001 16/300 
(5.3%) 
1.00  0.379
Yes  796/3559 
(22.4%) 
0.93 (0.71‐
1.21) 
  815/3559 
(22.9%) 
1.99 (1.51‐
2.63) 
  264/3559 
(7.4%) 
1.37 (0.68‐
2.74) 
 
How long has 
it been since 
your first 
positive HIV 
test? 
0‐11 months  212/750 
(28.3%) 
1.00  0.043 115/750 
(15.3%) 
1.00  <0.001 36/750 
(4.8%) 
1.00  0.097
1‐5 years  351/1543 
(22.7%) 
0.75 (0.59‐
0.96) 
342/1543 
(22.2%) 
1.51 (1.20‐
1.89) 
106/1543 
(6.9%) 
1.36 (0.85‐
2.18) 
More than 5 years 167/754 
(22.1%) 
0.73 (0.56‐
0.96) 
215/754 
(28.5%) 
2.04 (1.59‐
2.63) 
60/754 
(8.0%) 
1.53 (1.02‐
2.30) 
Skipped/missing  138/812 
(17.0%) 
‐    181/812 
(22.3%) 
    78/812 
(9.6%) 
‐   
How old were 
you the first 
time you had 
sex 
11‐15  157/632 
(24.8%) 
1.00  0.527 158/632 
(25.0%) 
1.00  0.361 45/632 
(7.1%) 
1.00  0.477
16‐18  421/1854 
(22.7%) 
0.91 (0.69‐
1.20) 
  414/1854 
(22.3%) 
0.83 (0.63‐
1.09) 
  139/1854 
(7.5%) 
1.00 (0.50‐
1.98) 
 
19‐24  213/964 
(22.1%) 
0.88 (0.63‐
1.24) 
215/964 
(22.3%) 
0.81 (0.62‐
1.05) 
81/964 
(8.4%) 
1.10 (0.57‐
2.13) 
25+  8/50 
(16.0%) 
0.59 (0.30‐
1.19) 
13/50 
(26.0%) 
0.99 (0.48‐
2.03) 
1/50 (2.0%)  0.25 (0.03‐
2.42) 
Skipped/missing 69/359 
(19.2%) 
‐ 53/359 
(14.8%) 
14/359 
(3.9%) 
‐ 
How many 
sexual 
partners have 
you had in 
your lifetime? 
1  120/639 
(18.8%) 
1.00  0.107 108/639 
(16.9%) 
1.00  0.002 39/639 
(6.1%) 
1.00  0.001
2‐5  520/2156 
(24.1%) 
1.38 (0.90‐
2.13) 
  518/2156 
(24.0%) 
1.55 (0.94‐
2.55) 
  168/2156 
(7.8%) 
1.29 (0.57‐
2.91) 
 
6‐10  88/410 
(21.5%) 
1.17 (0.68‐
2.02) 
  107/410 
(26.1%) 
1.76 (0.98‐
3.18) 
  32/410 
(7.8%) 
1.37 (0.40‐
4.72) 
 
11‐15  12/52 
(23.1%) 
1.27 (0.69‐
2.37) 
17/52 
(32.7%) 
2.46 (1.14‐
5.28) 
7/52 
(13.5%) 
2.64 (0.86‐
8.15) 
16‐20  7/28 
(25.0%) 
1.43 (0.54‐
3.75) 
11/28 
(39.3%) 
3.24 (1.40‐
7.53) 
5/28 
(17.9%) 
3.71 (0.61‐
22.63) 
More than 20  16/40 
(40.0%) 
2.73 (1.19‐
6.26) 
17/40 
(42.5%) 
3.91 (1.80‐
8.49) 
4/40 
(10.0%) 
2.24 (0.91‐
5.49) 
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Skipped/missing 105/534 
(19.7%) 
‐ 75/534 
(14.0%) 
25/534 
(4.7%) 
‐ 
The last time 
you had sex, 
did you use a 
condom 
No  250/1001 
(25.0%) 
1.00  0.323 236/1001 
(23.6%) 
1.00  0.187 66/1001 
(6.6%) 
1.00  0.604
Yes  413/1857 
(22.2%) 
0.86 (0.65‐
1.15) 
  394/1857 
(21.2%) 
0.87 (0.71‐
1.07) 
  137/1857 
(7.4%) 
1.11 (0.74‐
1.66) 
 
Skipped/missing  205/1001 
(20.5%) 
‐    223/1001 
(22.3%) 
    77/1001 
(7.7%) 
‐   
Wealth Tertile  Lowest  318/1547 
(20.6%) 
1.00 0.065 307/1547 
(19.8%) 
1.00 0.197 88/1547 
(5.7%) 
1.00  0.003
Middle  387/1583 
(24.4%) 
1.26 (1.03‐
1.55) 
364/1583 
(23.0%) 
1.19 (0.94‐
1.51) 
116/1583 
(7.3%) 
1.28 (0.99‐
1.66) 
Highest  163/729 
(22.4%) 
1.12 (0.84‐
1.51) 
182/729 
(25.0%) 
1.32 (0.96‐
1.80) 
76/729 
(10.4%) 
1.90 (1.30‐
2.79) 
Stigma 
experienced in 
the community 
No  486/3006 
(16.2%) 
1.00  <0.001 ‐  ‐    ‐  ‐   
Yes  382/853 
(44.8%) 
4.32 (3.47‐
5.37) 
  ‐  ‐    ‐  ‐   
Stigma 
experienced in 
a healthcare 
setting 
No  723/3579 
(20.2%) 
1.00  <0.001 616/3579 
(17.2%) 
1.00  <0.001 ‐  ‐   
Yes  145/280 
(51.8%) 
4.37 (2.71‐
7.06) 
237/280 
(84.6%) 
26.28 
(13.22‐
52.26) 
‐  ‐ 
aOR: adjusted Odds Ratio ; CI: Confidence Interval ; n: Number of individuals experiencing the three types of stigma within groups; N: 
Total number of individuals within groups; Pw: P value of the Wald test. 
a: The aOR for sex is adjusted for age group; The aOR for age group is adjusted for sex; The aOR for all other predictor variables are 
adjusted for sex and age group. 
b: A p value of less than 0.05 indicates that the predictorcreates a statistically significant improvement in the fit of the model. 
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Table 4: Association between attitudes and perceptions of stigma held by community members and 
health workers and levels of internalised and experienced stigma reported by people living with HIV 
adjusted for age, sex and clustering (n=3,859) 
 
Cluster‐level exposure variables  Any 
internalised 
stigma 
Any 
experienced 
stigma 
Stigma 
experience in a 
healthcare 
setting 
  aORscore(95% 
CI) for unit 
increase in 
score 
aORscore(95% 
CI) for unit 
increase in 
score 
aORscore(95% CI) 
for unit increase 
in score 
Average level of HIV fear and judgement reported by CM 1.11 (0.36‐3.44) 0.89 (0.31‐
2.58) 
‐ 
Average level of perceived HIV stigma in the community 
reported by CM 
3.36 (1.86‐6.10) 3.27 (1.31‐
8.19) 
‐ 
Average level of perceived HIV stigma in healthcare
settings reported by CM 
‐ ‐ 14.93 (3.95‐56.43)
Average level of HIV fear and judgement reported by 
HW 
‐ ‐ 0.02 (0.01‐1.60)
Average level of perceived HIV stigma in the community 
reported by HW 
0.16 (0.01‐2.34) 0.34 (0.07‐
1.71) 
‐ 
Average level of perceived co‐worker stigmatising 
behaviour reported by HW 
‐ ‐ 0.49 (0.01‐32.0)
aORscore: Adjusted Odds Ratio for age, sex and clustering within communities; CI: Confidence interval; CM: Community members 
not living with HIV; HW: Health workers not living with HIV.  
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